Project Grant HT94252510441
Award Date
9/1/25
Completion Date
8/31/29
Dollars Obligated
$1.2M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Gainesville, FL 32611, USA
Similar Awards
The University of Florida was awarded a $5.796 million Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) for the period of September 1, 2023 through August 31, 2027. The grant will support the development of clinical candidates for the treatment of Myotonic Dystrophy at the University's location in Gainesville, Florida. As the prime awardee, the University will leverage its expertise in biomedical research to...
This $1,104,029 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program will support research at the University of Florida to investigate MRI/MRS markers of skeletal muscle disease progression and vascular function in non-ambulatory individuals with Duchenne muscular dystrophy (DMD). The research will be conducted over a 3-year period from November 1, 2024 to October 31, 2027. The funding will enable the University of...
The University of Florida (UF) received a $1,524,836 Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct research on understanding and targeting common mechanisms of myotonic dystrophy types 1 and 2 using novel repeat expansion mouse models. The grant, which began on September 1, 2023 and will continue through August 31, 2027, supports UF's cutting-edge biomedical research efforts to transform healthcare for Service...
This $953,125 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program will support research at the University of Florida to investigate MRI/MRS markers of skeletal muscle disease progression and vascular function in nonambulatory individuals with Duchenne muscular dystrophy. The research project will run from November 1, 2024 to October 31, 2027 and aims to advance understanding of neurodegenerative diseases...
This $1,525,000 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports foundational studies at the University of Florida to understand the phenotypic, region-specific, and cell-specific dysregulation in the central nervous system of individuals with myotonic dystrophy. The 4-year award, effective May 15, 2024, will enable the university to conduct innovative research to advance the understanding of this neurological...
The University of Florida was awarded a $305,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from March 2021 through March 2024 to develop novel therapies for dystonia. Through this funding, the University of Florida Division of Sponsored Research will conduct research into medical solutions for dystonia that can potentially transform healthcare for service members and the...
The University of Florida was awarded a $304,894 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research to develop localized oxygen delivery using silk fibroin-based micro-particles loaded with salmon hemoglobin from March 15, 2021 through March 14, 2023. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of...
The federal Project Grant award of $1,700,000.00 was provided by the Department of Defense (DoD) through the Military Medical Research and Development (CFDA 12.420) program. The grant was awarded to the University of Miami's Office of Research Administration - School of Medicine Division on September 15, 2024, with a completion date of September 14, 2026. The funding supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the...
This $377,227 Project Grant was awarded on August 15, 2024 by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The prime awardee, Florida State University, will conduct research related to traumatic brain injury and psychological health. The funded project aims to develop innovative...
The University of Florida was awarded a $762,501 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The three-year award will support preclinical evaluation of an emergency-ready therapy for spinal cord injury from August 1, 2022 to July 31, 2025. The Military Medical Research and Development program aims to transform military and public health through innovative medical research solutions. This award will...